OTC Markets OTCPK - Delayed Quote USD

Medivolve Inc. (MEDVF)

0.0050 0.0000 (0.00%)
At close: June 11 at 10:16 AM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
686.4510
686.4510
1,388.4490
86,824.9870
10,583.2560
--
Cost of Revenue
111.1010
111.1010
575.6930
50,255.8870
5,976.8180
--
Gross Profit
575.3500
575.3500
812.7560
36,569.1000
4,606.4380
--
Operating Expense
3,948.4260
3,948.4260
13,925.2290
22,858.0640
13,156.5460
--
Operating Income
-3,373.0760
-3,373.0760
-13,112.4730
13,711.0360
-8,550.1080
--
Net Non Operating Interest Income Expense
-293.4140
-293.4140
-237.7450
-424.7280
-8,863.1310
--
Other Income Expense
-246.1650
-246.1650
-1,228.4520
-13,440.3460
-20,364.4170
--
Pretax Income
-3,912.6550
-3,912.6550
-14,578.6700
-154.0360
-37,777.6560
--
Tax Provision
--
--
-4,512.3480
6,456.4890
--
--
Net Income Common Stockholders
-16,457.8970
-16,457.8970
-18,365.3340
-6,610.5240
-37,777.6560
--
Diluted NI Available to Com Stockholders
-16,457.8970
-16,457.8970
-18,365.3340
-6,610.5240
-37,777.6560
--
Basic EPS
-0.61
-0.61
-0.68
-0.34
-5.70
--
Diluted EPS
-0.61
-0.61
-0.68
-0.34
-5.70
--
Basic Average Shares
27,019.2570
27,019.2570
27,016.1050
19,323.7130
6,673.0910
--
Diluted Average Shares
27,019.2570
27,019.2570
27,016.1050
19,323.7130
6,673.0910
--
Total Operating Income as Reported
-3,580.0320
-3,580.0320
-14,492.0190
-128.2320
-24,430.1530
--
Total Expenses
4,059.5270
4,059.5270
14,500.9220
73,113.9510
19,133.3640
--
Net Income from Continuing & Discontinued Operation
-16,457.8970
-16,457.8970
-18,365.3340
-6,610.5240
-37,777.6560
--
Normalized Income
-3,456.9760
-3,456.9760
-13,438.5440
2,092.5485
-17,413.2390
--
Interest Income
31.2670
--
0.2870
57.9720
60.6350
52.7370
Interest Expense
--
--
--
1,040.8980
4,240.0000
--
Net Interest Income
-293.4140
-293.4140
-237.7450
-424.7280
-8,863.1310
--
EBIT
-3,373.0760
-3,373.0760
-13,112.4730
13,711.0360
-33,537.6560
--
EBITDA
-2,972.8510
-2,972.8510
-11,566.6630
18,534.5120
-30,362.7830
--
Reconciled Cost of Revenue
111.1010
111.1010
575.6930
46,649.6300
2,913.3230
--
Reconciled Depreciation
400.2250
400.2250
1,545.8100
4,823.4760
3,174.8730
--
Net Income from Continuing Operation Net Minority Interest
-3,703.1410
-3,703.1410
-14,578.6700
-6,610.5240
-37,777.6560
--
Total Unusual Items Excluding Goodwill
-246.1650
-246.1650
-1,140.1260
-11,840.9150
-20,364.4170
--
Total Unusual Items
-246.1650
-246.1650
-1,140.1260
-11,840.9150
-20,364.4170
--
Normalized EBITDA
-2,726.6860
-2,726.6860
-10,426.5370
30,375.4270
-9,998.3660
--
Tax Rate for Calcs
--
--
--
0.0003
--
--
Tax Effect of Unusual Items
--
--
--
-3,137.8425
--
--
12/31/2019 - 12/18/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade